Domenico Praticó, MD, Scott Richards North Star Charitable Foundation Chair for Alzheimer’s Research; Professor in the Departments of Pharmacology, Microbiology and Immunology; and Director of the Alzheimer’s Center at Temple at the Lewis Katz School of Medicine (LKSOM); and a team of LKSOM researchers have shown for the first time that a molecule known as VPS35 detects and removes defective proteins, including a potentially harmful protein called tau, from neurons. Tau otherwise accumulates and contributes to neurodegenerative disorders, including Alzheimer’s disease. The findings were published online July 9 in the journal Molecular Psychiatry. Scienmag, Bioengineer.org, ScienceDaily, Neuroscience News, Medical Xpress, Medical News Today, and other outlets covered the news.
Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.
Learn More
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH